Susquehanna International Group’s bioAffinity Technologies BIAFW Stock Holding History

Susquehanna International Group’s Portfolio BIAFW Stock Details BIAFW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.63K	Buy	+11,013	New	+$3.49K	﹤0.01%	12999
2023 Q4	–	Sell	-10,525	Closed	-$961	–	12351
2023 Q3	$961	Buy	+10,525	New	+$3.14K	﹤0.01%	11878
2023 Q2	–	Sell	-14,077	Closed	-$4.22K	–	12072
2023 Q1	$4.22K	Sell	14,077 -13,071	-48%	-$4.88K	﹤0.01%	12323
2022 Q4	$11.4K	Buy	27,148 +963	+4%	+$424	﹤0.01%	11914
2022 Q3	$9K	Buy	+26,185	New	+$27.1K	﹤0.01%	12792

Other funds holding BIAFW

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group's BIAFW Position: Q1 2026 in Review

Susquehanna International Group opened a new position in bioAffinity Technologies (BIAFW) in Q1 2026: 11,013 shares worth $3.63K. The stake represents ﹤0.01% of the portfolio and ranks #12999 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in BIAFW as recently as Q3 2023.

Susquehanna International Group first reported a position in BIAFW in Q3 2022 and has held it in 5 quarters since. The position peaked at $11.4K in Q4 2022. 4 funds tracked by Wall St. Rank hold BIAFW as of Q1 2026.

Susquehanna International Group held 11,013 shares of bioAffinity Technologies worth $3.63K as of Q1 2026.
bioAffinity Technologies was a new Susquehanna International Group position in Q1 2026.
bioAffinity Technologies made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12999 holding.
Susquehanna International Group first reported a position in bioAffinity Technologies in Q3 2022 and has held it in 5 quarters since.
Susquehanna International Group's bioAffinity Technologies position peaked at $11.4K in Q4 2022.
4 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.